Antituberculosis drugs and hepatotoxicity

被引:54
作者
Sharma, S. K. [1 ]
机构
[1] All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India
关键词
D O I
10.1016/j.meegid.2003.01.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:167 / 170
页数:4
相关论文
共 44 条
[21]  
MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70
[22]   ACETYLATION RATES AND MONTHLY LIVER-FUNCTION TESTS DURING ONE YEAR OF ISONIAZID PREVENTIVE THERAPY [J].
MITCHELL, JR ;
LONG, MW ;
THORGEIRSSON, UP ;
JOLLOW, JD .
CHEST, 1975, 68 (02) :181-190
[23]  
Mohan A, 2004, Indian J Chest Dis Allied Sci, V46, P5
[24]   Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic [J].
Nolan, CM ;
Goldberg, SV ;
Buskin, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11) :1014-1018
[25]   Isoniazid for latent tuberculosis infection - Approaching 40 and reaching its prime [J].
Nolan, CM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (04) :412-413
[26]   Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients [J].
Ohkawa, K ;
Hashiguchi, M ;
Ohno, K ;
Kiuchi, C ;
Takahashi, S ;
Kondo, S ;
Echizen, H ;
Ogata, H .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) :220-226
[27]  
Ormerod P, 1998, THORAX, V53, P536
[28]   Risk factors for hepatotoxicity from antituberculosis drugs: A case-control study [J].
Pande, JN ;
Singh, SPN ;
Khilnani, GC ;
Khilnani, S ;
Tandon, RK .
THORAX, 1996, 51 (02) :132-136
[29]   HEPATIC TOXICITY IN SOUTH INDIAN PATIENTS DURING TREATMENT OF TUBERCULOSIS WITH SHORT-COURSE REGIMENS CONTAINING ISONIAZID, RIFAMPICIN AND PYRAZINAMIDE [J].
PARTHASARATHY, R ;
SARMA, GR ;
JANARDHANAM, B ;
RAMACHANDRAN, P ;
SANTHA, T ;
SIVASUBRAMANIAN, S ;
SOMASUNDARAM, PR ;
TRIPATHY, SP .
TUBERCLE, 1986, 67 (02) :99-108
[30]  
RISKA N, 1976, Bulletin of the International Union Against Tuberculosis, V51, P203